Achieve Life Sciences (ACHV) Net Equity Issued and Repurchased (2012 - 2020)
Achieve Life Sciences' (ACHV) quarterly Net Equity Issued and Repurchased came in at $9.0 million in Q4 2020, up 896800.0% on a QoQ basis from -$1000.0 in Q4 2018.
Achieve Life Sciences (ACHV) Net Equity Issued and Repurchased (2012 - 2020) Analysis & Trends
Achieve Life Sciences (ACHV) has 6 years of Net Equity Issued and Repurchased data on file, last reported at $9.0 million in Q4 2020.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $9.0 million in Q4 2020, while the trailing twelve-month figure through Dec 2021 was $9.0 million (down 1.91% YoY) and the FY2021 annual result came in at $21.3 million, up 35.18% from the prior year.
- Net Equity Issued and Repurchased advanced to $9.0 million in Q4 2020, from -$1000.0 in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $9.0 million in Q4 2020 to a low of -$1.1 million in Q4 2017.
- A 3-year average of $1.8 million and a median of $175000.0 in 2018 frame the typical range for Net Equity Issued and Repurchased.
- The widest YoY moves for Net Equity Issued and Repurchased: up 99.91% in 2018, down 99.91% in 2018.
- Tracing ACHV's Net Equity Issued and Repurchased over 3 years: stood at -$1.1 million in 2017, then soared by 99.91% to -$1000.0 in 2018, then jumped by 896800.0% to $9.0 million in 2020.
- The last three Net Equity Issued and Repurchased figures came in at $9.0 million (Q4 2020), -$1000.0 (Q4 2018), and $175000.0 (Q2 2018), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 141.90 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Achieve Life Sciences | 330.88 Mn | 330.88 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 8.97 Mn |
| Dec 31, 2020 | 8.97 Mn |
| Dec 31, 2018 | -1,000.00 |
| Dec 31, 2018 | -1,000.00 |
| Jun 30, 2018 | 175,000.00 |
| Jun 30, 2018 | 175,000.00 |
| Mar 31, 2018 | 1.11 Mn |
| Mar 31, 2018 | 1.11 Mn |
| Dec 31, 2017 | -1.07 Mn |
| Dec 31, 2017 | -1.07 Mn |
| Sep 30, 2015 | 14.42 Mn |
| Sep 30, 2015 | 14.42 Mn |
| Jun 30, 2015 | 213,000.00 |
| Jun 30, 2015 | 213,000.00 |
| Sep 30, 2014 | 19.51 Mn |
| Sep 30, 2014 | 19.51 Mn |
| Jun 30, 2014 | -11.22 Mn |
| Jun 30, 2014 | -11.22 Mn |
| Jun 30, 2012 | -23,000.00 |
| Jun 30, 2012 | -23,000.00 |